Country visit to Bulgaria to discuss policies relating to antimicrobial resistance
ECDC and the European Commission's Directorate General for Health and Food Safety jointly carried out this country visit to Bulgaria from 15 to 19 October 2018. The visit was carried out following the invitation from the competent authorities to assist them in the preparation of their national strategy for tackling antimicrobial resistance (AMR) based on a 'One Health' perspective.
Communicable disease threats report, 27 October-2 November 2019, week 44
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 27 October-2 November 2019 and includes updates on Ebola virus disease, mass gathering monitoring in Japan, MERS-CoV, West Nile virus and Zika fever.
Communicable disease threats report, Week 30, 19-25 July 2015
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 19-25 July 2015, and includes updates on anthrax, West Nile virus, Schistosoma haematobium, MERS, Ebola virus and polio.
Report of the joint ECDC and WHO review of the national tuberculosis programme in Bulgaria
This report outlines the results of the joint ECDC and WHO review of the Bulgarian National Tuberculosis Control Programme.
Technical mission: HIV, STI and viral hepatitis in Bulgaria. 19-21 September 2016 and 14-15 November 2016
The Ministry of Health in Bulgaria invited ECDC to prepare an assessment of the current national HIV programme and to review the STI and Hepatitis surveillance system. Following discussions between ECDC and representatives of the Bulgarian national programme, it was decided to split the assessment into two separate country missions.
ECDC workshop on social determinants and communicable diseases
Rapid Outbreak Assessment: Fatal human case of Bacillus anthracis infection and bovine meat contamination in Bulgaria, 7 August 2015
ECDC and EFSA have assessed the risk to the EU/EEA posed by a fatal human case of Bacillus anthracis infection in Bulgaria and concluded that this event represents a negligible risk to other EU/EEA countries.